Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarka in arterial hypertension
NCT00235001Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Jun 2004
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of trandolapril and verapamil in hypertension (HTN), sponsored by Abbott Laboratories. Primary endpoint: Change in blood pressure from baseline/blood pressure control at 3 months. Started Jun 2004; status: completed.
02
Drugs
trandolaprilverapamil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00235001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235001.